Obesity Severity and Cardiovascular Trajectories: Insights from the Cross-Cohort Collaboration
Posted inCardiology Clinical Updates Internal Medicine news

Obesity Severity and Cardiovascular Trajectories: Insights from the Cross-Cohort Collaboration

This review synthesizes findings from a 21- **Compiling final edits** Now that I've structured the article, I'm focusing on the final touches, particularly the content for the "Highlights," "Expert Commentary," and the "Conclusion" sections. I'm leveraging the provided literature, including the Dardari et al. study and related papers on GLP-1 agonists and dietary patterns, to build a cohesive narrative. The JSON schema is in its final phase of completion. I have successfully populated the `relative_articles` field. cohort study on 289,875 individuals, demonstrating that severe obesity (BMI ≥35 kg/m²) dramatically elevates risks for heart failure and atrial fibrillation, while revealing significant sex-based differences in stroke and mortality risk.
Global Variations in Patient Radiation Exposure for Coronary Artery Disease Diagnosis: A Synthesized Review of the INCAPS 4 Findings
Posted inCardiology Clinical Updates news Radiology

Global Variations in Patient Radiation Exposure for Coronary Artery Disease Diagnosis: A Synthesized Review of the INCAPS 4 Findings

This review analyzes global radiation doses in CAD diagnostic imaging based on the INCAPS 4 study. It highlights significant disparities across modalities and regions, revealing that patients in low-income countries and those undergoing CCTA face substantially higher radiation risks, necessitating urgent standardized protocols.
Posted inClinical Updates Infectious Diseases news Public Health

Long-term Immunological and Clinical Outcomes of Monkeypox Virus Infection versus MVA-BN Vaccination: A 24-Month Longitudinal Cohort Analysis

This 24-month Belgian cohort study demonstrates that natural MPXV infection induces more durable and robust immunity than MVA-BN vaccination. While clinical symptoms mostly resolve within a year, persistent scarring remains common, and vaccine-induced immunity wanes significantly, highlighting the potential need for booster strategies.